Placeholder Banner

BIO Sends Letter to President Biden Discussing Collaboration to Ensure Patient Access to COVID Treatments

March 8, 2021

BIO President and CEO Dr. Michelle McMurry-Heath sent President Biden a letter sharing thoughts on how to best work together with global partners to ensure that patients around the world get access to COVID vaccines, therapeutics, and diagnostics.

Download Full Comments Below
Letter to President Biden
Discover More
On Tuesday, April 6th, BIO submitted comments on the U.S. Food and Drug Administration (FDA)’s January 2021 draft industry guidance on “Human Gene Therapy for Neurodegenerative Diseases.” In its comments, BIO stated that while the guidance covers…
On Friday, March 26th, BIO submitted comments on the U.S. Food and Drug Administration (FDA)’s public meeting announcement titled, “Best Practices for Development and Application of Disease Progression Models.” BIO appreciates that FDA is seeking…
The Biotechnology Innovation Organization (BIO) submitted the below comments to the National Institute of Standards and Technology on proposed revisions to regulations that would further the Return on Investment (ROI) Initiative for Unleashing…